What is the next generation therapeutic strategy for castration-resistant prostate cancer

Prostate cancer (PCa) is one of the most common cancers in the world. Since androgen receptor (AR) signal plays key roles in the PCa progression, targeting androgens via the current androgen deprivation therapy (ADT) is the main therapeutic strategy for advanced PCa. However, most patients who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Si-Meng, Quan, Chang-Yi, Jiang, Ning, Shang, Zhi-Qun, Niu, Yuan-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Invited Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650465/
https://www.ncbi.nlm.nih.gov/pubmed/25432503
http://dx.doi.org/10.4103/1008-682X.143311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650465/
https://www.ncbi.nlm.nih.gov/pubmed/25432503
http://dx.doi.org/10.4103/1008-682X.143311

Ejemplares similares